PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2092789
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2092789
Blood Flow Measurement Devices market size was valued at US$ 890.2 Million in 2025, expanding at a CAGR of 10.1% from 2026 to 2033.
A blood flow measuring device is a type of equipment that is used to measure the speed at which blood flows in the blood vessels and tissue areas. Blood flow measuring devices are very significant in both the process of diagnosing and scientific research. This device allows increasing awareness about the condition of the heart, as well as human body physiology, and allows locating even the smallest issue in the circulatory system. These instruments improve diagnostic precision, treatment effectiveness, and the quality of patients' lives.
Blood Flow Measurement Devices Market- Market Dynamics
Increasing Prevalence of Peripheral Vascular Disorders to Propel Market Demand
The increasing prevalence of peripheral vascular disorders is driving demand in the Blood Flow Measurement Devices market because of the need for non-invasive diagnostic and measurement instruments that help in detecting, assessing, and managing blood flow in patients with peripheral vascular diseases. For instance, in 2025, according to the study published on NIH.gov, the peripheral vascular disorder patient population was projected to increase to up to 113 million individuals around the globe in the year 2025. Peripheral artery disease (PAD) alone (the main form of peripheral vascular disorder) has affected an estimated 1.52 percent of the population 40 and above globally and an estimate of 113 million cases from 65.8 million, demonstrating a 72 percent rise in incidence cases and this escalating vascular disease burden. Hence, growing disease prevalence will drive the demand for blood flow measurement devices.
The Global Blood Flow Measurement Devices market is segmented on the basis of Product, Application, End User, and Region.
The non-invasive application segment accounted for a notable share in the Blood Flow Measurement Devices market because it enables real-time monitoring of blood circulation and supports early diagnosis and management of cardiovascular diseases. In September 2025, Cook Medical joined hands with Siemens Healthineers to develop a new solution that would involve radiation-free imaging-guided intervention techniques by making use of real-time MRI along with their innovative minimally invasive medical device portfolio. This collaboration is expected to improve the visualization of vasculature and guide the procedures and increase the trend of adoption of non-invasive blood flow measurement techniques in medical devices.
Blood Flow Measurement Devices Market- Geographical Insights
North America holds a prominent position in the Blood Flow Measurement Devices market because of its robust healthcare facilities, technological advancements, and growing need for new and better diagnostic solutions. For instance, in 2025, according to the C.D. Howe Institute Org., the demand for innovative diagnostic solutions in Canada's healthcare system has grown as the average wait time for a specialist consultation has risen to 30 weeks, compared to 9.3 weeks 20 years ago that is an increase of 222% with 14% of Canadians having no family physician and another 19% not being able to get to see one almost 50% of the Canadian population while also 29% face access problems to a doctor. These trends continue to accelerate demand for advanced blood flow measurement devices across North America's healthcare sector.
United Arab Emirates Blood Flow Measurement Devices Market- Country Insights
The United Arab Emirates (UAE) is witnessing substantial growth in the number of healthcare initiatives, leading to an increase in the use of advanced hemodynamic monitoring technologies. For instance, in Aug 2025, according to a study published in the U.S. National Library of Medicine (PMC), the United Arab Emirates (UAE) has drastically increased its initiatives by strengthening its medical research ecosystem, evidenced by the fact that more than 43,000 health and medical research publications and over 2,300 clinical trials came from the UAE, with wide collaboration between local and international research teams. This will ensure that the country improves its healthcare innovation ecosystem, which will enhance its research capabilities and clinical advancements along with ensuring medical practice based on scientific evidence in the UAE. This will in turn boost the demand for blood flow measurement equipment across the UAE healthcare sector.
The Blood Flow Measurement Devices market is primarily characterized by Medtronic, GE HealthCare, Siemens Healthineers, Koninklijke Philips N.V., and Cook Medical offering different kinds of blood flow measurement monitors, vascular imaging, and blood flow monitoring diagnostic technologies. In June 2025, Koninklijke Philips N.V. signed a new multi-year partnership agreement with Medtronic in order to develop and implement innovative patient monitoring solutions such as pulse oximetry, capnography, and brain monitoring within Philips' IntelliVue monitoring system. This will help in advancing technology and increasing competition in the blood flow measurement devices market.
In March 2026, Medtronic extended the global strategic alliance between the two firms to develop next-generation patient monitoring and clinical integration technology solutions. These two firms have partnered to improve connectivity monitoring and streamline clinical workflow and to make innovative advancements in physiological and hemodynamic monitoring technology.
In September 2025, Cook Medical teamed up with Siemens Healthineers to provide the iMRI Suite, which is an innovative system that combines the use of MRI-compatible intervention devices and MR imaging. This innovation is intended to facilitate minimally invasive procedures on blood vessels and to improve visualization of blood flow during the procedures.